MedTrace Logo

Hematocrit Effect on a Blood Glucose Monitor

NCT05158478 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2022-07-28

No results posted yet for this study

Summary

This study assesses the repeatability precision of a blood glucose monitoring system pursuant to ISO 15197

Conditions

Interventions

DIAGNOSTIC_TEST

blood glucose measurement, blood glucose monitor for personal use

measurement of the blood glucose concentration using the blood glucose monitor for personal use (TJ100)

DIAGNOSTIC_TEST

blood glucose measurement, laboratory reference device

measurement of the blood glucose concentration using a laboratory reference device (YSI 2300 Stat Plus)

Sponsors & Collaborators

  • Tyson Bioresearch Inc., Kedong 3rd Rd., Zhunan Township, Miaoli County 35053, Taiwan

    collaborator UNKNOWN

  • Institut fur Diabetes Karlsburg GmbH

    lead OTHER

Principal Investigators

  • Eckhard Salzsieder, PhD · Institut fur Diabetes Karlsburg GmbH

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-22
Primary Completion
2022-02-22
Completion
2022-03-14

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05158478 on ClinicalTrials.gov